Genes coding for melanoma antigens recognised by cytolytic T lymphocytes

Eye

Volumn 11, Issue 2, 1997, Pages 243-248

  De Smet, Charles ^a,b   Lurquin, Christophe ^a   De Plaen, Etienne ^a   Brasseur, Francis ^a   Zarour, Hassane ^a   De Backer, Olivier ^a   Coulie, Pierre G ^a   Boon, Thierry ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

Immunotherapy; MAGE; Melanoma; Tumour antigen

Indexed keywords

CANCER VACCINE; DIFFERENTIATION ANTIGEN; MELANOMA ANTIGEN;

ANTIGEN EXPRESSION; CLASSIFICATION; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; GENE; GENE MUTATION; MOLECULAR RECOGNITION;

EID: 0030996740     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1997.59     Document Type: Conference Paper

References (48)

1. Greenberg PD. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol 1991;49:281-355.
2. Boon T, Cerottini J-C, Van den Eynde B, van der Bruggen P, Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 1994;12:337-65.
3. Hérin M, Lemoine C, Weynants P, Vessière F, Van Pel A, Knuth A, et al. Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int J Cancer 1987;39:390-6.
4. Lehmann F, Marchand M, Hainaut P, Pouillart P, Sastre X, Ikeda H, et al. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur J Immunol 1995;25:340-7.
5. Van den Eynde B, Hainaut P, Hérin M, Knuth A, Lemoine C, Weynants P, et al. Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer 1989;44:634-40.
6. Wölfel T, Hauer M, Klehmann E, Brichard V, Ackermann B, Knuth A, et al. Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL). Int J Cancer 1993;55:237-44.
7. - mutation. Proc Natl Acad Sci USA 1988;85:2274-8.
8. Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994;180:35-42.
9. Anichini A, Fossati G, Parmiani G. Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma. Int J Cancer 1985;36:683-9.
10. Darrow TL, Slingluff CLJ, Seigler HF. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes: evidence for shared tumor antigens. J Immunol 1989;142: 3329-35.
11. Kawakami Y, Zakut R, Topalian SL, Stötter H, Rosenberg SA. Shared human melanoma antigens: recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J Immunol 1992;148: 638-43.
12. Anichini A, Maccalli C, Mortarini R, Salvi S, Mazzocchi A, Squarcina P, et al. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J Exp Med 1993;177:989-98.
13. Brichard V, Van Pel A, Wölfel T, Wölfel C, De Plaen E, Lethé B, et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993;178: 489-95.
14. Wölfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Büschenfelde K-H, Boon T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 1994;24:759-64.
15. Brichard VG, Herman J, Van Pel A, Wildmann C, Gaugler B, Wölfel T, et al. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur J Immunol 1996;26:224-30.
16. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994;91:3515-9.
17. Kwon BS, Chintamaneni C, Kozak CA, Copeland NG, Gilbert DJ, Jenkins N, et al. A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is a syntenic region on human chromosome 12. Proc Natl Acad Sci USA 1991;88:9228-32.
18. Adema GJ, de Boer AJ, Vogel AM, Loenen WAM, Figdor CG. Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem 1994;269:20126-33.
19. Kawakami Y, Eliyahu S, Jennings C, Sakaguchi K, Kang X, Southwood S, et al. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 1995;154:3961-8.
20. Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994;264:716-9.
21. Kawakami Y, Eliyahu S, Delgado H, Robbins PF, Sakaguchi K, Appella E, et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994;91:6458-62.
22. Zarour H, De Smet C, Lehmann F, Marchand M, Lethé B, Romero P, et al. The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100. J Invest Dermatol 1996;107:63-7.
23. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
24. De Plaen E, Arden K, Taversari C, Gaforio JJ, Szikora J-P, De Smet C, et al. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics 1994;40:360-9.
25. Rogner UC, Wilke K, Steck E, Korn B, Poustka A. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics 1995;29:725-31.
26. Muscatelli F, Walker AP, De Plaen E, Stafford AN, Monaco AP. Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci USA 1995;92:4987-91.
27. Traversari C, van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992;176:1453-7.
28. Gaugler B, Van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994;179:921-30.
29. De Smet C, Lurquin C, van der Bruggen P, De Plaen, E, Brasseur F, Boon T. Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 1994;39:121-9.
30. Takahashi K, Shichijo S, Noguchi M, Hirohata M, Itoh K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 1995;55:3478-82.
31. Mulcahy KA, Rimoldi D, Brasseur F, Rodgers S, Liénard D, Marchand M, et al. Infrequent expression of the MAGE gene family in uveal melanomas. Int J Cancer 1996;66:738-42.
32. Brasseur F, Rimoldi D, Liénard D, Lethé B, Carrel S, Arienti F, et al. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 1995;63:375-80.
33. De Smet C, Courtois SJ, Faraoni I, Lurquin C, Szikora J-P, De Backer O, Boon, T. Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics 1995;42:282-90.
34. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 1996;93: 7149-53.
35. Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 1983;11:6883-94.
36. Bedford MT, van Helden PD. Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res 1987;47:5274-6.
37. Liteplo RC, Kerbel RS. Reduced levels of DNA 5-methylcytosine in metastatic variants of the human melanoma cell line MeWo. Cancer Res 1987;47:2264-7.
38. Rocamora N, Mezquita C. Chicken spermatogenesis is accompanied by a genome-wide loss of DNA methylation. FEBS Lett 1989;247:415-8.
39. del Mazo J, Prantera G, Miguel T, Ferraro M. DNA methylation changes during mouse spermatogenesis. Chromosome Res 1994;2:147-52.
40. Boël P, Wildmann C, Sensi M-L, Brasseur R, Renauld J-C, Coulie P, et al. BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995;2:167-75.
41. Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995;182:689-98.
42. Guilloux Y, Lucas S, Brichard VG, Van Pel A, Viret C, De Plaen E, et al. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J Exp Med 1996;183: 1173-83.
43. - transplantation antigen P91A: a peptide encoded by the mutated exon is recognized with Ld by cytolytic T cells. Cell 1989;58:293-303.
44. Coulie PG, Lehmann F, Lethé B. Herman J, Lurquin C, Andrawiss M, Boon T. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA 1995;92:7976-80.
45. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995;269:1281-4.
46. Bystryn J-C, Darrell R, Friedman RJ, Kopf A. Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol 1987;123: 1053-5.
47. Jassim A, Ollier W, Payne A, Biro A, Oliver RTD, Festenstein H. Analysis of HLA antigens on germ cells in human semen. Eur J Immunol 1989;19:1215-20.
48. Marchand M, Weynants P, Rankin E, Arienti F, Belli F, Parmiani G, et al. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 1995;63:883-5.